{"title":"99mtc焦磷酸盐摄取对可疑甲状腺素转甲状腺素型心脏淀粉样变性患者的预后价值。","authors":"Tomohi Ajima MD , Tadao Aikawa MD, PhD , Toshinori Saitou RT , Yuya Matsue MD, PhD , Shinichiro Fujimoto MD, PhD , Kazunori Omote MD, PhD , Tohru Minamino MD, PhD","doi":"10.1016/j.nuclcard.2025.102452","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to evaluate the prognostic value of myocardial <sup>99m</sup>Tc-pyrophosphate (PYP) uptake in patients undergoing PYP imaging for suspected transthyretin cardiac amyloidosis (ATTR-CA).</div></div><div><h3>Methods</h3><div>A retrospective analysis of 301 consecutive patients who underwent PYP imaging for suspected ATTR-CA was performed. Myocardial PYP uptake was graded visually using the Perugini classification (grade 0-3) and quantified by the heart-to-contralateral lung uptake (H/CL) ratio. The primary outcome was combined cardiac death and documented fatal ventricular arrhythmias (ventricular fibrillation [VF] and sustained ventricular tachycardia [VT] lasting >30 seconds).</div></div><div><h3>Results</h3><div>Among the 301 patients, 90 had positive myocardial PYP uptake on SPECT. During a median follow-up of 668 days (interquartile range, 186-868 days), 36 patients died, including 13 cardiac deaths. Fatal ventricular arrhythmias were documented in 6 patients (2 aborted VF and 4 sustained VT). The primary outcome occurred in 8 of 211 (4%) patients with negative PYP SPECT and in 10 of 90 (11%) patients with positive PYP SPECT. Kaplan–Meier analyses showed a significantly higher incidence of the primary outcome in patients with positive PYP SPECT than in those without (P=.018). In contrast, all-cause mortality did not differ significantly between the two groups (P=.36). Multivariable Cox proportional hazards regression analyses showed that PYP SPECT positivity was an independent predictor of the primary outcome in patients with suspected ATTR-CA (adjusted hazard ratio: 2.86 [95% confidence interval: 1.10-7.41]; P =.031).</div></div><div><h3>Conclusions</h3><div>Significant myocardial PYP uptake was associated with an increased risk of adverse cardiac events in patients with suspected ATTR-CA.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"51 ","pages":"Article 102452"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis\",\"authors\":\"Tomohi Ajima MD , Tadao Aikawa MD, PhD , Toshinori Saitou RT , Yuya Matsue MD, PhD , Shinichiro Fujimoto MD, PhD , Kazunori Omote MD, PhD , Tohru Minamino MD, PhD\",\"doi\":\"10.1016/j.nuclcard.2025.102452\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>This study aimed to evaluate the prognostic value of myocardial <sup>99m</sup>Tc-pyrophosphate (PYP) uptake in patients undergoing PYP imaging for suspected transthyretin cardiac amyloidosis (ATTR-CA).</div></div><div><h3>Methods</h3><div>A retrospective analysis of 301 consecutive patients who underwent PYP imaging for suspected ATTR-CA was performed. Myocardial PYP uptake was graded visually using the Perugini classification (grade 0-3) and quantified by the heart-to-contralateral lung uptake (H/CL) ratio. The primary outcome was combined cardiac death and documented fatal ventricular arrhythmias (ventricular fibrillation [VF] and sustained ventricular tachycardia [VT] lasting >30 seconds).</div></div><div><h3>Results</h3><div>Among the 301 patients, 90 had positive myocardial PYP uptake on SPECT. During a median follow-up of 668 days (interquartile range, 186-868 days), 36 patients died, including 13 cardiac deaths. Fatal ventricular arrhythmias were documented in 6 patients (2 aborted VF and 4 sustained VT). The primary outcome occurred in 8 of 211 (4%) patients with negative PYP SPECT and in 10 of 90 (11%) patients with positive PYP SPECT. Kaplan–Meier analyses showed a significantly higher incidence of the primary outcome in patients with positive PYP SPECT than in those without (P=.018). In contrast, all-cause mortality did not differ significantly between the two groups (P=.36). Multivariable Cox proportional hazards regression analyses showed that PYP SPECT positivity was an independent predictor of the primary outcome in patients with suspected ATTR-CA (adjusted hazard ratio: 2.86 [95% confidence interval: 1.10-7.41]; P =.031).</div></div><div><h3>Conclusions</h3><div>Significant myocardial PYP uptake was associated with an increased risk of adverse cardiac events in patients with suspected ATTR-CA.</div></div>\",\"PeriodicalId\":16476,\"journal\":{\"name\":\"Journal of Nuclear Cardiology\",\"volume\":\"51 \",\"pages\":\"Article 102452\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nuclear Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1071358125003265\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nuclear Cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1071358125003265","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis
Background
This study aimed to evaluate the prognostic value of myocardial 99mTc-pyrophosphate (PYP) uptake in patients undergoing PYP imaging for suspected transthyretin cardiac amyloidosis (ATTR-CA).
Methods
A retrospective analysis of 301 consecutive patients who underwent PYP imaging for suspected ATTR-CA was performed. Myocardial PYP uptake was graded visually using the Perugini classification (grade 0-3) and quantified by the heart-to-contralateral lung uptake (H/CL) ratio. The primary outcome was combined cardiac death and documented fatal ventricular arrhythmias (ventricular fibrillation [VF] and sustained ventricular tachycardia [VT] lasting >30 seconds).
Results
Among the 301 patients, 90 had positive myocardial PYP uptake on SPECT. During a median follow-up of 668 days (interquartile range, 186-868 days), 36 patients died, including 13 cardiac deaths. Fatal ventricular arrhythmias were documented in 6 patients (2 aborted VF and 4 sustained VT). The primary outcome occurred in 8 of 211 (4%) patients with negative PYP SPECT and in 10 of 90 (11%) patients with positive PYP SPECT. Kaplan–Meier analyses showed a significantly higher incidence of the primary outcome in patients with positive PYP SPECT than in those without (P=.018). In contrast, all-cause mortality did not differ significantly between the two groups (P=.36). Multivariable Cox proportional hazards regression analyses showed that PYP SPECT positivity was an independent predictor of the primary outcome in patients with suspected ATTR-CA (adjusted hazard ratio: 2.86 [95% confidence interval: 1.10-7.41]; P =.031).
Conclusions
Significant myocardial PYP uptake was associated with an increased risk of adverse cardiac events in patients with suspected ATTR-CA.
期刊介绍:
Journal of Nuclear Cardiology is the only journal in the world devoted to this dynamic and growing subspecialty. Physicians and technologists value the Journal not only for its peer-reviewed articles, but also for its timely discussions about the current and future role of nuclear cardiology. Original articles address all aspects of nuclear cardiology, including interpretation, diagnosis, imaging equipment, and use of radiopharmaceuticals. As the official publication of the American Society of Nuclear Cardiology, the Journal also brings readers the latest information emerging from the Society''s task forces and publishes guidelines and position papers as they are adopted.